Neoplasma Vol.71, No.1, p. 60–69, 2024
|
| Title: microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2 |
| Author: Jinsong Yang, Haoyi Xiang, Mengjing Cheng, Xue Jiang, Ying Chen, Lingyan Zheng, Senxiang Yan, Shufen Zhang, Cheng Zhang, Wei Chen, Dajin Chen |
|
Abstract: In various malignant tumors (including bladder cancer) poor prognosis is associated with hypoxia and therapeutic resistance. Evidence indicates that in bladder cancer, microRNAs (miRNAs) have vital functions in acquired drug resistance. However, the involvement of miRNAs in hypoxia-mediated bladder cancer doxorubicin (Dox) resistance is unknown. Herein, we showed that hypoxia and Dox treatment downregulated miR-15a-5p expression. Using UM-UC-3 and J82 bladder cancer cell lines and in vivo mouse models of bladder cancer, we confirmed that miR-15a-5p arrests tumor cell growth and Dox resistance in vitro and in vivo. Furthermore, we determined the interaction between miR-15a-5p and eukaryotic translation initiation factor 5A-2 (eIF5A2) using dual luciferase reporters and quantitative real-time reverse transcription polymerase chain reaction assays. We also showed that a miR-15a-5p agomir repressed EIF5A2 expression in bladder cancer cells, thereby inhibiting the epithelial-mesenchymal transition (EMT) induced by Dox or hypoxia. Moreover, ectopic expression of miR-15a-5p abrogated eIF5A2-mediated Dox resistance in bladder cancer cells. Collectively, these data indicated that hypoxia promotes tumor growth and chemoresistance through the HIF-1α/miR-15a-5p/eIFTA2/EMT pathway. This new finding not only has implications for improving our understanding of the Dox resistance process during bladder cancer progression but also indicates that the miR-15a-5p agomir is a promising tool to prevent Dox resistance in patients with bladder cancer.
|
|
| Keywords: microRNA-15a-5p; bladder cancer; doxorubicin resistance; eIF5A2; EMT |
|
|
Published online: 18-Mar-2024
|
| Year: 2024, Volume: 71, Issue: 1 |
Page From: 60, Page To: 69 |
doi:10.4149/neo_2024_230915N489
|
|
 download file |
|
|
|
|
